Literature DB >> 34874061

A lay navigator-led, early palliative care intervention for African American and rural family caregivers of individuals with advanced cancer (Project Cornerstone): Results of a pilot randomized trial.

J Nicholas Dionne-Odom1,2,3, Andres Azuero1, Richard A Taylor1, Chinara Dosse1, Avery C Bechthold1, Erin Currie1, Rhiannon D Reed4, Erin R Harrell5, Sally Engler1, Deborah B Ejem1, Nataliya V Ivankova6, Michelle Y Martin7, Gabrielle B Rocque2,3,8, Grant R Williams8, Marie A Bakitas1,2,3.   

Abstract

BACKGROUND: The objective of this study was to assess the feasibility, acceptability, and potential efficacy of ENABLE (Educate, Nurture, Advise, Before Life Ends) Cornerstone-a lay navigator-led, early palliative care telehealth intervention for African American/Black and/or rural-dwelling family caregivers of individuals with advanced cancer (ClinicalTrials.gov identifier NCT03464188).
METHODS: This was a pilot randomized trial (November 2019 to March 2021). Family caregivers of patients with newly diagnosed, stage III/IV, solid-tumor cancers were randomized to receive either an intervention or usual care. Intervention caregivers were paired with a specially trained lay navigator who delivered 6 weekly, 20-minute to 60-minute telehealth coaching sessions plus monthly follow-up for 24 weeks, reviewing skills in stress management, self-care, getting help, staying organized, and future planning. Feasibility was assessed according to the completion of sessions and questionnaires (predefined as a completion rate ≥80%). Acceptability was determined through intervention participants' ratings of their likelihood of recommending the intervention. Measures of caregiver distress and quality of life were collected at 8 and 24 weeks.
RESULTS: Sixty-three family caregivers were randomized (usual care, n = 32; intervention, n = 31). Caregivers completed 65% of intervention sessions and 87% of questionnaires. Average ratings for recommending the program were 9.4, from 1 (not at all likely) to 10 (extremely likely). Over 24 weeks, the mean ± SE Hospital Anxiety and Depression Scale score improved by 0.30 ± 1.44 points in the intervention group and worsened by 1.99 ± 1.39 points in the usual care group (difference, -2.29; Cohen d, -0.32). The mean between-group difference scores in caregiver quality of life was -1.56 (usual care - intervention; d, -0.07). Similar outcome results were observed for patient participants.
CONCLUSIONS: The authors piloted ENABLE Cornerstone, an intervention for African American and rural-dwelling advanced cancer family caregivers. The acceptability of the intervention and data collection rates were high, and the preliminary efficacy for caregiver distress was promising. LAY
SUMMARY: To date, very few programs have been developed to support under-resourced cancer family caregivers. To address this need, the authors successfully pilot tested an early palliative care program, called Educate, Nurture, Advise, Before Life Ends (ENABLE) Cornerstone, for African American and rural family caregivers of individuals with advanced cancer. Cornerstone is led by specially trained lay people and involves a series of weekly phone sessions focused on coaching caregivers to manage stress and provide effective support to patients with cancer. The authors are now testing Cornerstone in a larger trial. If the program demonstrates benefit, it may yield a model of caregiver support that could be widely implemented.
© 2021 American Cancer Society.

Entities:  

Keywords:  African American; cancer; family caregivers; palliative care; telehealth

Mesh:

Year:  2021        PMID: 34874061      PMCID: PMC8882155          DOI: 10.1002/cncr.34044

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.921


  31 in total

1.  Geographic access to hospice in the United States.

Authors:  Melissa D A Carlson; Elizabeth H Bradley; Qingling Du; R Sean Morrison
Journal:  J Palliat Med       Date:  2010-10-27       Impact factor: 2.947

2.  America's care of serious illness: a state-by-state report card on access to palliative care in our nation's hospitals.

Authors:  R Sean Morrison; Rachel Augustin; Phomdaen Souvanna; Diane E Meier
Journal:  J Palliat Med       Date:  2011-09-16       Impact factor: 2.947

Review 3.  A review of family caregiving intervention trials in oncology.

Authors:  Betty Ferrell; Elaine Wittenberg
Journal:  CA Cancer J Clin       Date:  2017-03-20       Impact factor: 508.702

4.  Racial variation in the cancer caregiving experience: a multisite study of colorectal and lung cancer caregivers.

Authors:  Michelle Y Martin; Sara Sanders; Joan M Griffin; Robert A Oster; Christine Ritchie; Sean M Phelan; Audie A Atienza; Katherine Kahn; Michelle van Ryn
Journal:  Cancer Nurs       Date:  2012 Jul-Aug       Impact factor: 2.592

5.  Benefits of Early Versus Delayed Palliative Care to Informal Family Caregivers of Patients With Advanced Cancer: Outcomes From the ENABLE III Randomized Controlled Trial.

Authors:  J Nicholas Dionne-Odom; Andres Azuero; Kathleen D Lyons; Jay G Hull; Tor Tosteson; Zhigang Li; Zhongze Li; Jennifer Frost; Konstantin H Dragnev; Imatullah Akyar; Mark T Hegel; Marie A Bakitas
Journal:  J Clin Oncol       Date:  2015-03-23       Impact factor: 44.544

6.  Preliminary results of the generation of a shortened quality-of-life assessment for patients with advanced cancer: the FACIT-Pal-14.

Authors:  Liang Zeng; Gillian Bedard; David Cella; Nemica Thavarajah; Emily Chen; Liying Zhang; Margaret Bennett; Kenneth Peckham; Sandra De Costa; Jennifer L Beaumont; May Tsao; Cyril Danjoux; Elizabeth Barnes; Arjun Sahgal; Edward Chow
Journal:  J Palliat Med       Date:  2013-04-16       Impact factor: 2.947

7.  Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide.

Authors:  Tammy C Hoffmann; Paul P Glasziou; Isabelle Boutron; Ruairidh Milne; Rafael Perera; David Moher; Douglas G Altman; Virginia Barbour; Helen Macdonald; Marie Johnston; Sarah E Lamb; Mary Dixon-Woods; Peter McCulloch; Jeremy C Wyatt; An-Wen Chan; Susan Michie
Journal:  BMJ       Date:  2014-03-07

8.  CONSORT 2010 statement: extension to randomised pilot and feasibility trials.

Authors:  Sandra M Eldridge; Claire L Chan; Michael J Campbell; Christine M Bond; Sally Hopewell; Lehana Thabane; Gillian A Lancaster
Journal:  BMJ       Date:  2016-10-24

9.  Family Caregiver Depressive Symptom and Grief Outcomes From the ENABLE III Randomized Controlled Trial.

Authors:  J Nicholas Dionne-Odom; Andres Azuero; Kathleen D Lyons; Jay G Hull; Anna T Prescott; Tor Tosteson; Jennifer Frost; Konstantin H Dragnev; Marie A Bakitas
Journal:  J Pain Symptom Manage       Date:  2016-06-03       Impact factor: 3.612

10.  The Challenges of Enrollment and Retention: A Systematic Review of Psychosocial Behavioral Interventions for Patients With Cancer and Their Family Caregivers.

Authors:  Lixin Song; Yousef Qan'ir; Ting Guan; Peiran Guo; Shenmeng Xu; Ahrang Jung; Eno Idiagbonya; Fengyu Song; Erin Elizabeth Kent
Journal:  J Pain Symptom Manage       Date:  2021-04-30       Impact factor: 5.576

View more
  2 in total

1.  Web-Based Peer Navigation for Men with Prostate Cancer and Their Family Caregivers: A Pilot Feasibility Study.

Authors:  Jacqueline L Bender; Parminder K Flora; Shimae Soheilipour; Mihaela Dirlea; Nandini Maharaj; Lisa Parvin; Andrew Matthew; Charles Catton; Leah Jamnicky; Philip Pollock; Winkle Kwan; Antonio Finelli; Arminée Kazanjian
Journal:  Curr Oncol       Date:  2022-06-15       Impact factor: 3.109

2.  The Project ENABLE Cornerstone randomized controlled trial: study protocol for a lay navigator-led, early palliative care coaching intervention for African American and rural-dwelling advanced cancer family caregivers.

Authors:  Avery C Bechthold; Andres Azuero; Maria Pisu; Jennifer Young Pierce; Grant R Williams; Richard A Taylor; Rachel Wells; Kayleigh Curry; Rhiannon D Reed; Erin R Harrell; Shena Gazaway; Sarah Mollman; Sally Engler; Frank Puga; Marie A Bakitas; J Nicholas Dionne-Odom
Journal:  Trials       Date:  2022-06-02       Impact factor: 2.728

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.